Align Technology Earnings Call Highlights Global Aligner Momentum

Align Technology ((ALGN)) has held its Q1 earnings call. Read on for the main highlights of the call.

Align Technology’s latest earnings call struck a cautiously upbeat tone, with management emphasizing record Clear Aligner volumes, broad international growth and expanding margins. Executives highlighted strong cash generation and active capital returns, while acknowledging macro and geopolitical headwinds, softer North American demand and rising costs that temper, but do not erase, the positive momentum.

Topline Growth Supported by Clear Aligner Demand

Align reported Q1 revenue of $1.041 billion, up 6.2% year over year, helped by a roughly 4.5% constant‑currency tailwind worth about $44.9 million. Management attributed most of the growth to solid Clear Aligner demand, reinforcing the category as the company’s main engine even as some regions and product lines lagged.

Record Clear Aligner Volume and Improving ASPs

Clear Aligner shipments reached a record 686,000 cases, up 6.7% from a year ago and 1.3% sequentially, driving Clear Aligner revenue to $856 million, up 7.4% year over year. Average selling price per case ticked up about 1% to $1,250, providing modest pricing support despite mix and discount pressures that management warned could reverse later this year.

Broad-Based Patient and Channel Expansion

Patient metrics underscored broad demand, with 449,000 adults treated, up 7.8% year over year, and 237,000 teens and kids, up 4.8%. Shipments rose double digits across EMEA, APAC and Latin America, while both orthodontists and general practitioners grew, and dental service organizations delivered double‑digit volume growth to about a quarter of global cases.

Margins and Profitability Move Higher

Profitability improved as GAAP gross margin climbed to 70.8%, up 1.4 points, with Clear Aligner gross margin at 71.6%, up 1.1 points. GAAP operating margin reached 13.6%, edging higher year over year, while non‑GAAP operating margin expanded to 21.5% and non‑GAAP EPS jumped 21% to $2.58, signaling better efficiency and scale benefits.

Strong Cash Generation and Capital Returns

Align ended the quarter with $1.06 billion in cash and equivalents, up $186.8 million from a year ago, supported by $151 million of operating cash flow and $120.3 million of free cash flow. The company completed a $200 million share repurchase and authorized up to another $200 million over six months, leaving roughly $800 million still available for future buybacks.

Systems and Platform Adoption Reaches New Milestones

The company’s digital platform continued to deepen its footprint, with the active base of iTero scanners surpassing 125,000 and more than 12 million iTero scans performed in the quarter. Exocad delivered double‑digit revenue growth, while the Invisalign ART pilot in the U.S. and early iTero Lumina uptake helped Systems & Services revenue reach $184.1 million.

Commercial Initiatives Gain Momentum

Management pointed to the Doctor Subscription Program as a key growth lever, noting double‑digit gains in subscriptions and related touch‑up cases across regions. Patient financing solutions such as HFD in more than 4,000 U.S. offices and the rapid adoption of Invisalign Pay in Brazil are improving affordability, conversion and overall aligner adoption.

Operational Efficiencies and Revenue Recognition Tailwinds

Align’s shift toward treatment configurations with fewer ongoing obligations reduced Clear Aligner deferred revenue by $77.2 million, or 6.4% year over year, improving revenue timing and cash conversion. Management also cited lower refinement rates, better treatment predictability and enhanced manufacturing throughput as structural drivers supporting margins going forward.

North America Softness Offsets International Strength

Despite global growth, North America Clear Aligner volumes showed a modest year‑over‑year decline that management characterized as a stable but negative drag. International markets, particularly EMEA, APAC and Latin America, delivered double‑digit shipment growth, underscoring a regional imbalance in the company’s revenue mix.

Systems & Services Face Seasonal and Mix Headwinds

Systems & Services revenue of $184.1 million grew just 0.9% from a year earlier and fell sequentially, consistent with management’s seasonal expectations. A shift toward lower‑priced, PC‑based scanners and more leasing or rental arrangements pressured average selling prices, limiting growth despite expanding scanner adoption.

Operating Expenses Rise on Legal and Compensation Costs

Operating expenses increased to $594.6 million, up 8.3% year over year, with non‑GAAP operating expenses up 4.5% to $523.1 million. Executives cited legal settlement costs and higher employee compensation as key drivers, partially offsetting margin gains and signaling that cost discipline will remain a focus area.

Mix, Discounts and ASP Pressure Loom

While Clear Aligner ASPs improved slightly this quarter, management noted that higher discounts and greater exposure to lower‑priced countries and products weighed on revenue. The company now expects a 1% to 2% decline in ASPs for the full year, suggesting that volume growth rather than pricing will be the primary lever for topline expansion.

Macro and Geopolitical Risks Remain a Watch Point

Executives flagged uncertainty tied to military conflict in the Middle East, which could affect patient traffic, consumer demand and logistics costs, including freight and fuel. These risks have been factored into near‑term guidance, and management indicated they are monitoring the situation closely for any escalation that could spill into broader demand.

Input Cost Exposure and Working Capital Considerations

Align highlighted that roughly a quarter of its cost of goods sold is tied to resin and plastics, leaving margins exposed to swings in oil and resin prices. Accounts receivable remain high at about $1.125 billion, with days sales outstanding at 97 days, flat year over year, underscoring ongoing working capital requirements as the business scales.

Guidance Balances Growth Ambitions with Caution

For Q2 2026, Align guided revenue to $1.040 billion to $1.060 billion, up roughly 3% to 5% with Clear Aligner volumes rising and Systems & Services improving sequentially, while assuming some impact from Middle East turmoil. For the full year, the company reaffirmed 3% to 4% revenue growth, mid‑single‑digit Clear Aligner case growth, a 1% to 2% ASP decline, higher GAAP and non‑GAAP operating margins, modest FX benefits, moderate capex and an additional $200 million share buyback over six months.

Align’s earnings call painted a picture of a business leaning on volume growth, international expansion and margin improvement to drive shareholder value, even as North American softness and macro risks persist. For investors, the combination of resilient demand, expanding digital platforms and active capital returns offers a constructive thesis, though execution on costs and regional reacceleration will be crucial to sustaining the current trajectory.